Congratulations, Prince William & Duchess Catherine!

In response to the announcement of Catherine, Duchess of Cambridge’s third pregnancy and treatment for hyperemesis gravidarum (HG), the Hyperemesis Education and Research (HER) Foundation extends best wishes for the health of mother and baby during this joyful yet challenging time.

Distinct from “morning sickness” common in most healthy pregnancies, HG is characterized by weight loss, malnutrition, and dehydration due to severe vomiting and/or nausea. Severity and duration of symptoms vary, but HG remains the leading cause of hospitalization in early pregnancy and a debilitating medical condition that can have serious health consequences for both mom and baby. It is particularly threatening to mothers without immediate access to effective treatment and IV nutritional support.

Duchess_of_Cambridge_June_2013“While the Duchess of Cambridge is undoubtedly receiving the proactive and knowledgeable care that has an enormous positive impact on her and the baby’s health, our hearts go out to her as she again experiences the disruption of health, work, and family life that many thousands of HG women endure each year.” said Kimber Wakefield MacGibbon, R.N., HER Foundation co-founder and director. “It is our hope that through increased funding for HG research, in addition to education, we can restore some of the pregnancy joy for mothers with HG, so they and their babies have a healthier future.”

The Duchess’s third pregnancy comes at a time of great promise and hope for HG women and families:

About HER Foundation
For 15 years, the Hyperemesis Education and Research (HER) Foundation has been the global voice of HG. HER is the leading source of information, advocacy and support worldwide, and helps improve the health of many women and children.

Comments are closed.